Pancreatic cancer mortality in Egypt: Comparison to the United States pancreatic cancer mortality rates
Cancer Detection and Prevention · 2006-01 · 30 (5) · 473-479
DOI: 10.1016/j.cdp.2006.06.006 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Detection and Prevention, 2006-01. Verfasst von Amr S Soliman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA. asoliman@umich.edu. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
OBJECTIVES: Little is known about the descriptive epidemiology of pancreatic cancer in many developing countries, such as Egypt. It is believed to be rare in developing countries, but this may reflect lack of systematic cancer registration. Mortality may serve as a surrogate for incidence, since the disease is lethal. Because of availability of reliable mortality registration in Egypt, we used the national mortality data to estimate pancreatic cancer mortality in 2765 deaths from 2000 to 2004, and to gain insights into the disease incidence. METHODS: Mortality data in Egypt was obtained from the electronic national mortality records of the Ministry of Health. We calculated population-based age-specific and age-standardized pancreatic cancer mortality rates for Egypt, and compared them with the Surveillance, Epidemiology, and End Results (SEER) mortality data of the United States. RESULTS: Comparisons of age-specific mortality demonstrated higher rates in Egypt compared to the United States for subjects under age 20 years (relative risks (RR) of 7.7 and 4.2, for the age groups 0-15 and 15-20, respectively), and significantly higher rates in the United States compared to Egypt for subjects 40 years and older (RR 1.8-80.5 for the age groups of 40-45 to 75+). For the majority of age groups in Egypt and the United States, mortality in males was higher than in females. Analysis of regional distribution of pancreatic cancer mortality in Egypt showed significant variations in rates among provinces (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA. asoliman@umich.edu
Förderung
- NCI NIH HHS
Zitieren
APA
Soliman, A. S., Zhang, Q., Saleh, T., Zarzour, A., Selim, M., Abdel-Fattah, M., & Abbruzzese, J. L. (2006). Pancreatic cancer mortality in Egypt: Comparison to the United States pancreatic cancer mortality rates. Cancer Detection and Prevention, 30(5), 473-479. https://doi.org/10.1016/j.cdp.2006.06.006
Vancouver
Soliman AS, Zhang Q, Saleh T, Zarzour A, Selim M, Abdel-Fattah M, et al. Pancreatic cancer mortality in Egypt: Comparison to the United States pancreatic cancer mortality rates. Cancer Detection and Prevention. 2006;30(5):473-479. doi:10.1016/j.cdp.2006.06.006
BibTeX
@article{Soliman2006,
author = {Soliman, Amr S and Zhang, Qing and Saleh, Thanaa and Zarzour, Ali and Selim, Mohei and Abdel-Fattah, Mahmoud and Abbruzzese, James L},
title = {Pancreatic cancer mortality in Egypt: Comparison to the United States pancreatic cancer mortality rates},
journal = {Cancer Detection and Prevention},
year = {2006},
volume = {30},
number = {5},
pages = {473--479},
doi = {10.1016/j.cdp.2006.06.006}
}
EUVIMED